Andrew J. Armanino - 18 Dec 2023 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Director
Signature
/s/ Leslie Miller, Attorney-in-fact
Issuer symbol
BTTX on OTC
Transactions as of
18 Dec 2023
Net transactions value
$0
Form type
4
Filing time
20 Dec 2023, 17:22:11 UTC
Previous filing
02 Nov 2023
Next filing
05 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Award $0 +3,750 +28% $0.000000 17,084 18 Dec 2023 Direct F1
holding BTTX Common Stock 728,368 18 Dec 2023 By Armanino Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
F2 These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust", and directly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.